With the recent European Commission approval of zolbetuximab plus chemotherapy for certain adults with gastric or gastroesophageal junction adenocarcinoma, Cancer Nursing Today spoke with experts about the approval, the data behind it, and what nurses should know about caring for patients receiving this treatment. ...